Navigation Links
Spectral OCT/SLO

ProductsSpectral OCT/SLO
Company OTI Ophthalmic Technologies Inc.
Item Spectral OCT/SLO
Features 
  • High Speed Scanning of optical coherence tomography (OCT) images up to 50 times faster than time domain
  • Ultra High resolution imaging of 5-6 microns
  • Simultaneous SLO imaging for real time registration and orientation
  • Accurate and easy reproducibily with SLO imaging
  • Real-Time Cross-Sectional OCT and SLO image
  • Horizontal and Vertical Views, split screen with SLO, black and white, colour
  • Accurate registration of 3D information
  • Line scan, automatic raster scan, radial scan modes
  • Advanced 3D Topgraphic and Tomographic Measurements and Comparisons
  • RNFL and Optic Nerve Thickness and Volume Measurements for Glaucoma
  • Affordable Multimodality System
  • Microperimetry Option
Description OTI's new Spectral system is a combination Spectral Optical Coherence Tomography (OCT) and Scanning Laser Ophthalmoscope (SLO) system that provides suberb, high-quality images of the vitreo-retina, retina, and choroidal-retina structure. With the advancements of spectral technology, OTI's sytem can reach scanning rates of up to 27,000 A-Scans per second and provide images with a resolution of 5-6 microns.

The unique dual optical coherence tomography (OCT) and SLO imaging of OTI's system provides a confocal fundus image allowing for accurate point to point registration and orientation of the B-Scan image in real-time. Other spectral systems are using 3D reconstructions to help identify the location of the B-Scan, by creating quasi-SLO images from large 3D images. These images, which are rendered and manipulated after the scan, are time consuming, and slow down patient throughput. With OTI's system, this information is available on-screen in real time.

OTI's new system offers a wide range of clincial possiblilities with its ability to provide high resolution B-Scan images, 3D Tomographic and Topographic data, and Optic Nerve and RNFL data for monitoring glaucoma patients. Its ability to fuse with other modalities such as optional Microperimetry make it an affordable, space-saving alternative to purchasing an entirely new system for this function.

Info OTI Ophthalmic Technologies Inc.
Customer Service: (888) 517-4444
Web site: http://www.oti-canada.com

Related medicine products :

1. HearTwave II Microvolt T-Wave Alternans System With Analytic Spectral Method
... BD Persist contains 70% alcohol and ... unique polymer base, forming a barrier ... a protective environment for the povidone ... most commonly associated with catheter related ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
Triad Plus PVP-I Prep Solution has broad-spectrum germicidal action. Povidone Iodine Solution using an innovative one-piece screw cap, Triad Plus bottles are designed specifically to meet the needs o...
... Aplicare's Saturated Swabsticks are packaged ... Each 4 inch Swabstick is saturated ... solution. Each package is terminally sterilized, ... the patient. It acts as a ...
Medicine Products:
(Date:9/16/2014)... Thompson HealthDay Reporter MONDAY, ... strong heart fitness can delay a man,s onset of age-related ... suggests. Blood pressure naturally increases as people grow older ... with strong cardio-fitness don,t start drifting toward high blood pressure ... usually experience the early signs of high blood pressure in ...
(Date:9/16/2014)... A mathematical model that replicates Ebola outbreaks can no ... the current epidemic, finds research conducted by the University ... Warwick Mathematics Institute, developed a model that incorporated data ... , The research, titled Epidemiological Dynamics of Ebola ... when applying the available data from the ongoing 2014 ...
(Date:9/16/2014)... 15, 2014Patients with inoperable, early-stage lung cancer who ... five-year survival rate of 40 percent, according to ... Radiation Oncology,s (ASTRO,s) 56th Annual Meeting. Such a ... conventional RT resulted in poor tumor control for ... an update of RTOG 0236, originally published in ...
(Date:9/16/2014)... YORK, NY (September 16, 2014) The Columbia ... the 2014 Higher Education Excellence in Diversity (HEED) ... and largest diversity-focused publication in higher education. As ... honor recognizing U.S. colleges and universities that demonstrate ... be featured along with 82 other recipients in ...
(Date:9/16/2014)... September 16, 2014. Kessler Foundation researchers have published ... speed in the executive deficits found in individuals ... speed account for executive deficits in multiple sclerosis? ... published online ahead of print on August 18 ... authors are Victoria Leavitt, PhD, of the Manhattan ...
Breaking Medicine News(10 mins):Health News:Blood Pressure Seems to Stay Lower Longer in Fitter Men 2Health News:Blood Pressure Seems to Stay Lower Longer in Fitter Men 3Health News:Ebola outbreak 'out of all proportion' and severity cannot be predicated 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 3Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4
... ... of young adults with disabilities and adjusting to college life. , ... Wellesley, MA (PRWEB) Jan. 26, 2010 ... services, announced that its ChildRC.com web site now features a very informative and exciting ...
... , WASHINGTON , Jan. 26 ... Dateline NBC documentary on patients who have insurance but not adequate ... to deal with the lack of legal accountability for insurers and ... , The nonprofit consumer group called upon Obama to close ...
... , WASHINGTON , Jan. 26 The ... nonpartisan individual membership association of state legislators -- congratulates Pennsylvania ... for filing House Bills 2053 and 2179, which protect the ... Baker and Schroder will hold a joint press conference tomorrow at ...
... NC What does evolution a field that often ... with preventing and treating disease in our lifetime? A lot, ... may soon be tested on evolution in medical entrance and ... A collection of articles in the January 26 issue ...
... European Commission consultation on the EU Clinical Trials Directive, ... proposals by its member organisations for adapting the Directive,s ... treatment. Since the implementation of the Directive ... concerned about the detrimental effect it has had, particularly ...
... 2010 A Universit de Montral research team is developing ... brain to stop eating. "Mice deprived of leptin will not ... around," says Mose Bendayan, a pathology professor at the Universit ... protein extensively. Leptin regulates appetite in mammals and its ...
Cached Medicine News:Health News:ChildRC.com Features “Acclimating To College Life In A Wheelchair” 2Health News:Obama: Make Equal Justice for Patients a State of the Union Pledge & Re-establish White House Office of Consumer Affairs 2Health News:Obama: Make Equal Justice for Patients a State of the Union Pledge & Re-establish White House Office of Consumer Affairs 3Health News:Pennsylvania Legislators Stand for Health Care Freedom 2Health News:Pennsylvania Legislators Stand for Health Care Freedom 3Health News:Pennsylvania Legislators Stand for Health Care Freedom 4Health News:Medical students may soon be tested on evolution 2Health News:Medical students may soon be tested on evolution 3Health News:European Cancer Organization supports a revision of the EU Clinical Trials Directive 2Health News:European Cancer Organization supports a revision of the EU Clinical Trials Directive 3Health News:A gimmick-free weight-loss pill in the works 2
(Date:9/16/2014)... LONDON , Sept. 16, 2014 ... wound closure market, Frost & Sullivan recognises Incisive ... Award for Customer Value Leadership. Incisive Surgical,s uniquely-designed, ... closure technology that eliminates the need for patients ... punctures and staple removal  that may result in ...
(Date:9/16/2014)... Sept. 16, 2014  Synereca Pharmaceutics, Inc. ... orally active drugs that restore or increase ... a $1.4 million convertible debt financing. Accele ... sciences accelerator Accele Biopharma, Inc., led the ... nationally recognized private not-for-profit corporation focused on ...
(Date:9/16/2014)... Sept. 16, 2014  Relmada Therapeutics, Inc., (OTCBB: RLMD), ... of chronic pain, announced today that it has entered ... (MSKCC) in a series of animal studies for levorphanol, ... extended release form of levorphanol.  Gavril Pasternak, MD, PhD, ... Dr. Pasternak said, "Levorphanol is a ...
Breaking Medicine Technology:Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 3Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 5Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3